RIL
TLSI icon

Rothschild Investment LLC’s TriSalus Life Sciences TLSI Stock Holding History

Rothschild Investment LLC’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314 Buy
69
+67
+3,350% +$266 ﹤0.01% 3360
2026
Q1 		$8 Buy
2
+1
+100% +$5 ﹤0.01% 3584
2025
Q4 		$7 Buy
+1
New +$6 ﹤0.01% 3392

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Rothschild Investment LLC's TLSI Position: Q2 2026 in Review

Rothschild Investment LLC increased its TriSalus Life Sciences (TLSI) stake by 3,350% in Q2 2026, buying an estimated $266 and bringing the position to 69 shares worth $314. The position accounts for ﹤0.01% of the portfolio, ranked #3360.

Rothschild Investment LLC first reported a position in TLSI in Q4 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Rothschild Investment LLC held 69 shares of TriSalus Life Sciences worth $314 as of Q2 2026.
  • Rothschild Investment LLC bought 67 TriSalus Life Sciences shares in Q2 2026, an estimated $266.
  • TriSalus Life Sciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3360 holding.
  • Rothschild Investment LLC first reported a position in TriSalus Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.